This study is accepting new patients by invitation only
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
Summary
- Location
- at Oakland, California and other locations
- Dates
- study startedstudy ends around
- Principal Investigator
- by Hind Al Saif
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Hind Al Saif
Associate Professor, Pediatrics, School of Medicine. Authored (or co-authored) 13 research publications
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- BioMarin Pharmaceutical
- ID
- NCT07073014
- Phase
- Phase 3 Hypochondroplasia Research Study
- Study Type
- Interventional
- Participants
- Expecting 140 study participants
- Last Updated